Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa D Edwards

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Thorax|March 19, 2015
One-year change in health status and subsequent outcomes in COPDSarah Wilke, Paul W Jones, H Müllerova, et al.
Annals of the American Thoracic Society|February 3, 2015
Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysisStephen I Rennard, Nicholas Locantore, Bruno Delafont, et al.
Respiratory Medicine|August 17, 2010
Montelukast added to fluticasone propionate does not alter inflammation or outcomesRatko Djukanović, Susan J Wilson, Wendy C Moore, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2006
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterolNizar N Jarjour, Susan J Wilson, Steven M Koenig, et al.
Thorax|December 7, 2013
Lessons from ECLIPSE: a review of COPD biomarkersRosa Faner, Ruth Tal-Singer, John H Riley, et al.
Journal of the American Medical Directors Association|July 23, 2011
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary diseaseMartijn A Spruit, Michael I Polkey, Bartolome Celli, et al.
Thorax|January 30, 2014
Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortalityMichelle C Williams, John T Murchison, Lisa D Edwards, et al.
The Lancet. Respiratory Medicine|January 17, 2014
The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE studyHarvey O Coxson, Asger Dirksen, Lisa D Edwards, et al.
The European Respiratory Journal|March 25, 2016
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPDRoberto A Rabinovich, Bruce E Miller, Karolina Wrobel, et al.
American Journal of Respiratory and Critical Care Medicine|December 25, 2012
Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalizationMichael I Polkey, Martijn A Spruit, Lisa D Edwards, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Thorax|March 19, 2015
One-year change in health status and subsequent outcomes in COPDSarah Wilke, Paul W Jones, H Müllerova, et al.
Annals of the American Thoracic Society|February 3, 2015
Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysisStephen I Rennard, Nicholas Locantore, Bruno Delafont, et al.
Respiratory Medicine|August 17, 2010
Montelukast added to fluticasone propionate does not alter inflammation or outcomesRatko Djukanović, Susan J Wilson, Wendy C Moore, et al.
The Journal of Allergy and Clinical Immunology|July 4, 2006
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterolNizar N Jarjour, Susan J Wilson, Steven M Koenig, et al.
Thorax|December 7, 2013
Lessons from ECLIPSE: a review of COPD biomarkersRosa Faner, Ruth Tal-Singer, John H Riley, et al.
Journal of the American Medical Directors Association|July 23, 2011
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary diseaseMartijn A Spruit, Michael I Polkey, Bartolome Celli, et al.
Thorax|January 30, 2014
Coronary artery calcification is increased in patients with COPD and associated with increased morbidity and mortalityMichelle C Williams, John T Murchison, Lisa D Edwards, et al.
The Lancet. Respiratory Medicine|January 17, 2014
The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE studyHarvey O Coxson, Asger Dirksen, Lisa D Edwards, et al.
The European Respiratory Journal|March 25, 2016
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPDRoberto A Rabinovich, Bruce E Miller, Karolina Wrobel, et al.
American Journal of Respiratory and Critical Care Medicine|December 25, 2012
Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalizationMichael I Polkey, Martijn A Spruit, Lisa D Edwards, et al.
Pageof 5